Viva Biotech Holdings 2023 SR
The report highlights Viva Biotech's 2023 performance as a global drug discovery and production platform, achieving revenue of RMB2,155.6 million. Key achievements include the launch of new technology platforms like V-DEL and molecular glue, supported by a total R&D investment of RMB128 million. The company successfully introduced strategic investors with US$225 million in financing to support sustainable growth. Environmentally, the Group met several short-term targets by significantly reducing greenhouse gas emissions and water intensity in its CDMO segment. Socially, the company maintained a strong focus on employee health and safety, conducting over 3,000 safety trainings and reporting zero work-related fatalities.
Company: Viva Biotech Holdings
Sector: Health Care
Country: China
Year: 2023
Type: SR
Pages: 99
Viva Biotech Holdings
ESG Report
The report highlights Viva Biotech's 2023 performance as a global drug discovery and production platform, achieving revenue of RMB2,155.6 million. Key achievements include the launch of new technology platforms like V-DEL and molecular glue, supported by a total R&D investment of RMB128 million. The company successfully introduced strategic investors with US$225 million in financing to support sustainable growth. Environmentally, the Group met several short-term targets by significantly reducing greenhouse gas emissions and water intensity in its CDMO segment. Socially, the company maintained a strong focus on employee health and safety, conducting over 3,000 safety trainings and reporting zero work-related fatalities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Published
Apr 23, 2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees